Literature DB >> 19300869

Imaging and biomarkers will be used for detection and monitoring progression of early Alzheimer's disease.

M W Weiner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19300869     DOI： 10.1007/s12603-009-0032-y

Source DB:  PubMed          Journal:  J Nutr Health Aging        ISSN： 1279-7707            Impact factor:   4.075


× No keyword cloud information.
  17 in total

1.  Knowing the natural course of biomarkers in AD: longitudinal MRI, CSF and PET data.

Authors:  W M Van Der Flier; P Scheltens
Journal:  J Nutr Health Aging       Date:  2009-04       Impact factor: 4.075

2.  Neuro-imaging: structural and functional imaging.

Authors:  G B Frisoni
Journal:  J Nutr Health Aging       Date:  2009-04       Impact factor: 4.075

3.  How can we recognize "disease modification" effects?

Authors:  E R Siemers
Journal:  J Nutr Health Aging       Date:  2009-04       Impact factor: 4.075

4.  Interpreting biomarker data in therapeutic trials.

Authors:  P S Aisen
Journal:  J Nutr Health Aging       Date:  2009-04       Impact factor: 4.075

5.  Biomarkers for Alzheimer's disease trials--biomarkers for what? A discussion paper.

Authors:  S Lovestone; M Thambisetty
Journal:  J Nutr Health Aging       Date:  2009-04       Impact factor: 4.075

6.  Challenges in the conduct of disease-modifying trials in AD: practical experience from a phase 2 trial of Tau-aggregation inhibitor therapy.

Authors:  C Wischik; R Staff
Journal:  J Nutr Health Aging       Date:  2009-04       Impact factor: 4.075

7.  Molecular imaging markers in clinical trials in Alzheimer s disease.

Authors:  A Nordberg
Journal:  J Nutr Health Aging       Date:  2009-04       Impact factor: 4.075

Review 8.  Use of biomarkers to select the target population for clinical trials in subjects with mild cognitive impairment.

Authors:  P J Visser
Journal:  J Nutr Health Aging       Date:  2009-04       Impact factor: 4.075

9.  What we have learned from the Xaliproden Sanofi-aventis trials.

Authors:  P Douillet; J M Orgogozo
Journal:  J Nutr Health Aging       Date:  2009-04       Impact factor: 4.075

Review 10.  The validity of biomarkers as surrogate endpoints in Alzheimer's disease by means of the Quantitative Surrogate Validation Level of Evidence Scheme (QSVLES).

Authors:  C C Gispen-de Wied; M Kritsidima; A J A Elferink
Journal:  J Nutr Health Aging       Date:  2009-04       Impact factor: 4.075
View more
  5 in total

Review 1.  The Alzheimer's disease neuroimaging initiative: progress report and future plans.

Authors:  Michael W Weiner; Paul S Aisen; Clifford R Jack; William J Jagust; John Q Trojanowski; Leslie Shaw; Andrew J Saykin; John C Morris; Nigel Cairns; Laurel A Beckett; Arthur Toga; Robert Green; Sarah Walter; Holly Soares; Peter Snyder; Eric Siemers; William Potter; Patricia E Cole; Mark Schmidt
Journal:  Alzheimers Dement       Date:  2010-05       Impact factor: 21.566

Review 2.  The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.

Authors:  Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; Enchi Liu; John C Morris; Ronald C Petersen; Andrew J Saykin; Mark E Schmidt; Leslie Shaw; Judith A Siuciak; Holly Soares; Arthur W Toga; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2011-11-02       Impact factor: 21.566

Review 3.  2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.

Authors:  Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Jesse Cedarbaum; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; Johan Luthman; John C Morris; Ronald C Petersen; Andrew J Saykin; Leslie Shaw; Li Shen; Adam Schwarz; Arthur W Toga; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2015-06       Impact factor: 21.566

4.  Alzheimer disease identification using amyloid imaging and reserve variables: proof of concept.

Authors:  C M Roe; M A Mintun; N Ghoshal; M M Williams; E A Grant; D S Marcus; J C Morris
Journal:  Neurology       Date:  2010-07-06       Impact factor: 9.910

Review 5.  The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.

Authors:  Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; Enchi Liu; John C Morris; Ronald C Petersen; Andrew J Saykin; Mark E Schmidt; Leslie Shaw; Li Shen; Judith A Siuciak; Holly Soares; Arthur W Toga; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2013-08-07       Impact factor: 21.566
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.